YILING ZENG: Open Payments
NPI 1922348390 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,521 in 30 payments from 15 companies in 2025. Trend: 2023 $549 · 2024 $414 · 2025 $1,521
Food & beverage: $1,521
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $437 |
| Gilead Sciences, Inc. | 6 | $361 |
| BridgeBio Pharma, Inc. | 1 | $150 |
| Agios Pharmaceuticals, Inc. | 1 | $138 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Esperion Therapeutics, Inc. | 3 | $59 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Medtronic, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $26 |
Products named: AIRSUPRA, BREZTRI, Attruby, PYRUKYND, JARDIANCE, Livdelzi, NEXLETOL, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
